H
Loading...
Loading...
Biodynamic hematogel is an autologous PRP-based wound gel. The published 96.5% positive-response figure is product-level clinical experience, not a per-city trial. Made-in-USA processing does not replace debridement and offloading.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18.
Biodynamic hematogel achieves 96.5% positive response rate in wound healing. PRP-based gel made in the USA.
Hematogel is a PRP-based wound gel made at the point of care. It is not a skin substitute on a claim. The 96.5% positive-response figure is product-level clinical experience. Chart the wound, then apply.
Prepare autologous gel, apply to a prepared bed, secondary dressing. Staff can learn the steps in a short in-service if the wound protocol already exists.
It is not an FDA label claim of cure and not a promise for every Wagner grade. Put the number in context when you talk to physicians.
Do not treat hematogel as a CTP skin substitute on the claim without coder/MAC agreement.
Yes — patient’s blood.
Yes, as stated on our product materials.
No. Wound-bed gel vs. intra-articular injection.
Yes, application and documentation.
Contact us today to learn how Hawk Medical can support your practice.
We're not just a distributor - we're healthcare providers who understand your challenges
We own and operate medical clinics, so we understand your real-world challenges
All products meet strict regulatory requirements including HCT/P 361 compliance
Personal account management and ongoing training for your entire team
10+ years of experience helping practices implement successful programs
Learn more about related treatments, solutions, and resources
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.